Anivive Awarded $500,000 Grant by the FDA for Canine Cancer Studies
Anivive Awarded $500,000 Grant by the FDA for Canine Cancer Studies - Anivive is the first recipient to be awarded a MUMS grant during this round of funding - Funding will accelerate ongoing canine lymphoma studies - Anivive to initiate studies of verdinexor to treat other types of cancer News provided by Share this article Share this article LONG BEACH, Calif., July 8, 2021 /PRNewswire/ -- Anivive, a pet health technology company transforming the therapeutic discovery and development process, ...
Prnewswire Anivive David Bruyette Carrie Wood Anivive Lifesciences Inc Minor Species Animal Health Act Dean For Research Dr
Source: prnewswire.com